Internal Medicine, Nephrology · Roseville, MI
NPI
1881647584
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
25710 Kelly Rd Ste 1
Roseville, MI, 48066
Phone (586) 772-2600
Groups this clinician bills Medicare through
Medicare paid, 2024
$459K
5,800 services
Medicare patients, 2024
983
Average age 75
Drug cost, 2024
$2.4M
7,023 prescriptions
Company payments, 2025
$1,487
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abdul R Effendi was code 99232 (hospital e&m - subsequent), 2,155 times for 411 patients. In total Abdul R Effendi billed 5,800 services in 32 codes, and Medicare paid $459K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 2,155 | 411 | $62.96 | $136K |
| 99233 Hospital E&M - Subsequent | Facility | 968 | 315 | $94.39 | $91K |
| 99214 Office E&M - Established | Office | 934 | 406 | $79.60 | $74K |
| 36415 Venipuncture Blood Collection | Office | 496 | 252 | $7.70 | $3,819 |
| 99222 Hospital E&M - Initial | Facility | 360 | 304 | $104.70 | $38K |
| 90960 ESRD Related Services (not dialysis) | Office | 191 | 41 | $280.49 | $54K |
| 99223 Hospital E&M - Initial | Facility | 145 | 129 | $137.20 | $20K |
| 99204 Office E&M - New | Office | 89 | 89 | $126.69 | $11K |
| 99213 Office E&M - Established | Office | 63 | 59 | $56.93 | $3,586 |
| 99231 Hospital E&M - Subsequent | Facility | 63 | 36 | $39.95 | $2,517 |
| 99221 Hospital E&M - Initial | Facility | 48 | 48 | $67.37 | $3,234 |
| 96372 Injection Administration | Office | 39 | 23 | $10.13 | $395 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 36 | 20 | $0.89 | $31.88 |
| 90935 Hemodialysis | Facility | 31 | 23 | $56.30 | $1,745 |
| 90961 ESRD Related Services (not dialysis) | Office | 28 | 19 | $233.06 | $6,526 |
By year: 2022 $262K for 4,257 services; 2023 $292K for 8,165 services; 2024 $459K for 5,800 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 496 | 252 | $7.70 | $3,819 |
Medicare prescription drug claims, 2024
In 2024, the drug Abdul R Effendi prescribed most often to Medicare patients was Chlorthalidone, with 718 prescriptions and refills. In total Abdul R Effendi wrote 7,023 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Chlorthalidone Generic | 718 | 1,699 | 281 | $11K |
| Jardiance Empagliflozin | 484 | 756 | 115 | $430K |
| Farxiga Dapagliflozin Propanediol | 398 | 702 | 94 | $370K |
| Allopurinol Generic | 362 | 796 | 99 | $3,829 |
| Ozempic Semaglutide | 350 | 465 | 73 | $410K |
| Losartan Potassium Generic | 345 | 842 | 111 | $3,315 |
| Atorvastatin Calcium Generic | 205 | 496 | 69 | $2,417 |
| Torsemide Generic | 204 | 406 | 85 | $2,676 |
| Calcitriol Generic | 191 | 446 | 66 | $4,011 |
| Irbesartan Generic | 190 | 503 | 106 | $4,769 |
| Nifedipine Er Nifedipine | 168 | 327 | 43 | $4,959 |
| Kerendia Finerenone | 167 | 301 | 36 | $186K |
| Mounjaro Tirzepatide | 166 | 179 | 38 | $179K |
| Trulicity Dulaglutide | 164 | 192 | 28 | $178K |
| Valsartan Generic | 130 | 327 | 45 | $5,139 |
Brand drugs: 2,293 claims; generic drugs: 4,679 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abdul R Effendi $1,487 ($1,487 in general payments such as food, travel and fees) from 18 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $315.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 22 | $315 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $304 |
| Amgen Inc. AMGN | 8 | $137 |
| Bard Peripheral Vascular, Inc. BDX | 2 | $137 |
| Novo Nordisk Inc NVO | 4 | $102 |
| Ardelyx, Inc. ARDX | 3 | $70.16 |
| Shield Therapeutics Inc STX.L | 3 | $60.89 |
| Lilly USA, LLC LLY | 3 | $59.21 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $53.12 |
| Scpharmaceuticals Inc. SCPH | 2 | $38.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.